Biomedical Imaging

The silent progression of liver-induced cognitive decline has historically lacked a precise neuroimaging signature that accounts for both physiological structure and active neuronal firing. The application of regional homogeneity and amplitude of low-frequency fluctuation ratios has uncovered

Triple-negative breast cancer remains a significant therapeutic challenge due to its aggressive nature and the absence of common hormonal receptors. Because patients lack estrogen, progesterone, and HER2 receptors, standard endocrine therapies and HER2-targeted treatments are ineffective, leaving

Blocking the movement of misfolded alpha-synuclein through the cerebrospinal fluid could potentially quarantine pathology and slow the progression of MSA. This perspective represents a fundamental shift in how the medical community approaches neurodegenerative disorders in 2026. Multiple System

Future efforts will focus on scaling the model across multiple institutions to enhance its predictive robustness and clinical utility in various settings. Imagine a patient undergoing a routine CT scan for an injury, while an invisible digital eye simultaneously identifies signs of chronic kidney

Magnetic resonance imaging's multiplanar capabilities allow for the identification of tubular duplications that run parallel to the segment of the fetal bowel. This sophisticated imaging modality has fundamentally shifted the diagnostic landscape for clinicians managing rare congenital anomalies

A significant challenge in oncology is that nearly one-quarter of breast cancer diagnoses involve aggressive HER2-positive tumors that require immediate and effective neoadjuvant therapy. This aggressive subtype is defined by an overabundance of the HER2 protein, which promotes the rapid growth of